Anne Knisely, a 69-year-old female with a history of endometrial cancer, presented with left leg pain, pleuritic chest pain, and shortness of breath. Imaging revealed extensive bilateral pulmonary emboli, right heart strain, and lower extremity deep vein thrombi. She was managed with anticoagulation

3 views • 11 slides

Recent studies have shown advancements in anticoagulation therapy for cancer patients with venous thromboembolism (VTE) and stroke prevention. Direct oral anticoagulants (DOACs) are now considered beneficial for treating VTE in cancer, offering advantages in administration and efficacy. Different an

3 views • 9 slides

Explore the world of anticoagulants through images, covering different types like warfarin and NOACs, their indications such as AF, DVT, and PE, monitoring in clinics, and specific drug details like apixaban, rivaroxaban, dabigatran, and edoxaban. Get insights into dosages, administration, and drug

0 views • 27 slides

This study aims to characterize the plasma levels of Dabigatran, Rivaroxaban, and Apixaban in patients with non-valvular atrial fibrillation (NVAF) who have been taking these drugs for more than 4 days. The research also assesses median trough plasma levels of these anticoagulants, as well as their

0 views • 18 slides

Patients with COVID-19 are at higher risk of thrombotic events, and antithrombotic regimens have shown varied results in previous trials. The APOLLO trial investigated the use of apixaban for prophylaxis in outpatients with additional risk factors. Results indicated that low-dose apixaban did not si

0 views • 18 slides